Stockscreener 앱 받기
4.19
2.95%
0.12
시간 외 거래:
4.20
0.010
+0.24%
전일 마감가:
$4.07
열려 있는:
$4.13
하루 거래량:
1.48M
Relative Volume:
0.29
시가총액:
$1.12B
수익:
-
순이익/손실:
$-252.18M
주가수익비율:
-3.9528
EPS:
-1.06
순현금흐름:
$-185.29M
1주 성능:
-4.99%
1개월 성능:
+5.54%
6개월 성능:
+43.49%
1년 성능:
+153.94%
1일 변동 폭
$4.02
$4.20
1주일 범위
$3.93
$4.40
52주 변동 폭
$1.26
$7.30
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
4.19 | 1.08B | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | Wedbush | Outperform |
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Big Picture: Can Sana Biotechnology Inc stock sustain market leadership - moha.gov.vn
Institutional Investors May Overlook Sana Biotechnology, Inc.'s (NASDAQ:SANA) Recent US$120m Market Cap Drop as Long-term Gains Remain Positive - 富途牛牛
Sana Biotechnology (NASDAQ:SANA) Shares Down 3.3%Time to Sell? - MarketBeat
Sana Biotech Stock Triples After Type 1 Diabetes Trial Wows Analysts: Retail Erupts In Excitement - MSN
Sana Biotechnology Showcases Successful In Vivo Gene Editing of Stem Cells in Nature Publication - Finviz
Seattle InnoSana and Bothell I Following up with ZenLedger - The Business Journals
Corient Private Wealth LLC Has $3.10 Million Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
How Sana Biotechnology Inc. stock performs in weak economyJuly 2025 Technicals & Reliable Price Breakout Alerts - Улправда
Sana Biotechnology (NASDAQ:SANA) Upgraded at Wall Street Zen - MarketBeat
How resilient is Sana Biotechnology Inc. stock in market downturns2025 Top Decliners & Low Risk Entry Point Guides - Улправда
Can Sana Biotechnology Inc. stock maintain operating marginsWeekly Market Report & Stepwise Entry/Exit Trade Alerts - DonanımHaber
Can Sana Biotechnology Inc. stock sustain revenue growth2025 Technical Patterns & Real-Time Market Sentiment Reports - DonanımHaber
Sana Biotechnology (NASDAQ:SANA) Stock Price Down 5.5%Here's What Happened - MarketBeat
CFO Wyrick Acquires 2,527 Of Sana Biotechnology Inc [SANA] - TradingView — Track All Markets
Sana Biotechnology, Inc. (SANA) insider details RSU vesting and stock sale - Stock Titan
Can Sana's Gene Editing Break New Ground In Treating Complex Diseases? - RTTNews
Marex Group plc Takes $10.42 Million Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Breakout Move: How interest rate cuts could boost Sana Biotechnology Inc stockQuarterly Profit Review & AI Powered Buy/Sell Recommendations - moha.gov.vn
Sana Biotechnology Reports Reduced Losses and Strong Liquidity - MSN
Sana Biotechnology (NASDAQ:SANA) Trading Up 8.8%Still a Buy? - MarketBeat
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Sana Biotechnology Stock: Soar or Sputter? - StocksToTrade
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.9%Time to Sell? - MarketBeat
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - The Manila Times
Sana Biotechnology Announces Publication in Nature - GlobeNewswire
Buyout Rumor: How Sana Biotechnology Inc stock performs in weak economyNew Guidance & Daily Profit Maximizing Trade Tips - moha.gov.vn
Sana (SANA) Surges 14.5% Ahead of Business Announcements - MSN
Is Sana Biotechnology's (SANA) SC451 Pivot Quietly Redefining Its Long-Term Platform Strategy? - simplywall.st
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Quantisnow
Sana Biotechnology’s Surging Stock: Buy or Sell? - StocksToTrade
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Sana Biotechnology (NASDAQ:SANA) Trading Up 6.6%Should You Buy? - MarketBeat
Sana Biotechnology (SANA) Stock Analysis Report | Financials & Insights - Benzinga
Will Sana Biotechnology’s (SANA) Pipeline Focus Reveal Strategic Priorities in Diabetes and Autoimmune Innovation? - Yahoo Finance
Sana Biotechnology Beats Earnings Estimates, Prioritizes SC451 and CAR T - StocksToTrade
Sana Biotechnology Surges Amid Strong Q3 Earnings Performance - timothysykes.com
Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains - Yahoo Finance
Sana Biotechnology (SANA): Evaluating Valuation After Recent Surge in Share Price - Sahm
10 Small Stocks with Mighty Gains - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Trading 12.8% HigherStill a Buy? - MarketBeat
Sana Biotechnology to Present at December 2025 Investor Conferences - GlobeNewswire
Sana Biotechnology, Inc. to Webcast Presentations at December Investor Conferences - Quiver Quantitative
Sana Biotechnology (NASDAQ: SANA) to Present at 2025 Citi and Evercore Conferences - Stock Titan
Sana Biotechnology (NASDAQ:SANA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Why Sana Biotechnology Inc. stock could benefit from AI revolutionWatch List & Fast Gaining Stock Strategy Reports - newser.com
Can Sana Biotechnology Inc. stock deliver surprise earnings beat2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.57%
자본화:
|
볼륨(24시간):